Comparison of Continuous and Pulsatile Apomorphine in Parkinson's Disease

NCT00758368 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Inadequate support to conduct the study

Conditions

Parkinson's Disease

Interventions

DRUG: Apomorphine

Sponsor

Oregon Health and Science University

Collaborators

[object Object]